-
European Commission approves Watson-Actavis merger
PARSIPPANY, N.J. — European regulators have approved U.S. drug maker Watson's acquisition of Switzerland-based Actavis, Watson said.
Watson said the European Commission had approved its $5.6 billion purchase of the drug maker, formerly based in Iceland, which Watson announced in April 2012.
Watson expects the transaction to be finished by the end of this year, subject to regulatory approval by the Federal Trade Commission. The acquisition is expected to create the world's third-largest generic drug maker.
-
FDA, Interpol collaborate on crackdown of illegal Web pharmacies
SILVER SPRING, Md. — In partnership with international regulatory and law enforcement agencies, the Food and Drug Administration on Thursday announced it had taken action against more than 4,100 Internet pharmacies that illegally sell unapproved drugs to consumers. Actions taken include civil and criminal charges, seizure of illegal products and removal of offending websites.